These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11160707

  • 1. Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells.
    Höfelmayr H, Strobl LJ, Marschall G, Bornkamm GW, Zimber-Strobl U.
    J Virol; 2001 Mar; 75(5):2033-40. PubMed ID: 11160707
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.
    Gordadze AV, Peng R, Tan J, Liu G, Sutton R, Kempkes B, Bornkamm GW, Ling PD.
    J Virol; 2001 Jul; 75(13):5899-912. PubMed ID: 11390591
    [Abstract] [Full Text] [Related]

  • 6. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M, Lundgren E.
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [Abstract] [Full Text] [Related]

  • 7. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters.
    Höfelmayr H, Strobl LJ, Stein C, Laux G, Marschall G, Bornkamm GW, Zimber-Strobl U.
    J Virol; 1999 Apr; 73(4):2770-80. PubMed ID: 10074124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.
    Cotter M, Callahan J, Aster J, Robertson E.
    J Virol; 2000 Feb; 74(3):1486-94. PubMed ID: 10627560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.
    Oncogene; 2004 Apr 08; 23(15):2681-93. PubMed ID: 14767477
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
    Rowe M, Raithatha S, Shannon-Lowe C.
    J Virol; 2014 Oct 08; 88(20):12065-76. PubMed ID: 25122803
    [Abstract] [Full Text] [Related]

  • 20. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
    Dudziak D, Kieser A, Dirmeier U, Nimmerjahn F, Berchtold S, Steinkasserer A, Marschall G, Hammerschmidt W, Laux G, Bornkamm GW.
    J Virol; 2003 Aug 08; 77(15):8290-8. PubMed ID: 12857898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.